FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 167 filers reported holding FIBROGEN INC in Q3 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,146 | -70.9% | 92,884 | -8.9% | 0.00% | – |
| Q2 2023 | $275,360 | -82.5% | 101,984 | +21.1% | 0.00% | -100.0% |
| Q1 2023 | $1,571,602 | +2.5% | 84,223 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $1,533,085 | +13.7% | 95,698 | -7.7% | 0.00% | 0.0% |
| Q3 2022 | $1,348,000 | +29.0% | 103,626 | +4.7% | 0.00% | 0.0% |
| Q2 2022 | $1,045,000 | -7.1% | 98,933 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $1,125,000 | -14.0% | 93,571 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $1,308,000 | +9.3% | 92,752 | -20.8% | 0.00% | 0.0% |
| Q3 2021 | $1,197,000 | -57.6% | 117,160 | +10.5% | 0.00% | -50.0% |
| Q2 2021 | $2,823,000 | -28.5% | 106,008 | -6.8% | 0.00% | -42.9% |
| Q1 2021 | $3,948,000 | +3.1% | 113,737 | +10.1% | 0.01% | 0.0% |
| Q4 2020 | $3,831,000 | -24.1% | 103,283 | -15.8% | 0.01% | -30.0% |
| Q3 2020 | $5,046,000 | +18.9% | 122,732 | +17.2% | 0.01% | 0.0% |
| Q2 2020 | $4,245,000 | +6.5% | 104,722 | -9.3% | 0.01% | -9.1% |
| Q1 2020 | $3,986,000 | -19.1% | 115,503 | +0.6% | 0.01% | +10.0% |
| Q4 2019 | $4,927,000 | +31.3% | 114,832 | +13.1% | 0.01% | 0.0% |
| Q3 2019 | $3,752,000 | -21.7% | 101,540 | -4.0% | 0.01% | -16.7% |
| Q2 2019 | $4,793,000 | -14.8% | 105,774 | +2.4% | 0.01% | -25.0% |
| Q1 2019 | $5,625,000 | +89.3% | 103,344 | +61.3% | 0.02% | +60.0% |
| Q4 2018 | $2,972,000 | -31.9% | 64,074 | -11.0% | 0.01% | -16.7% |
| Q3 2018 | $4,363,000 | -8.3% | 71,968 | -5.4% | 0.01% | -20.0% |
| Q2 2018 | $4,759,000 | +40.1% | 76,095 | +3.6% | 0.02% | +36.4% |
| Q1 2018 | $3,397,000 | +3.3% | 73,455 | +6.2% | 0.01% | +10.0% |
| Q4 2017 | $3,287,000 | +32.2% | 69,183 | +49.6% | 0.01% | +11.1% |
| Q3 2017 | $2,487,000 | +71.2% | 46,250 | +2.7% | 0.01% | +80.0% |
| Q2 2017 | $1,453,000 | +93.0% | 45,032 | +46.3% | 0.01% | +66.7% |
| Q1 2017 | $753,000 | +39.2% | 30,778 | +21.4% | 0.00% | +50.0% |
| Q4 2016 | $541,000 | +6.9% | 25,357 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $506,000 | +108.2% | 24,608 | +66.3% | 0.00% | +100.0% |
| Q2 2016 | $243,000 | -48.5% | 14,800 | -26.6% | 0.00% | 0.0% |
| Q2 2015 | $472,000 | – | 20,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |